Seeking Alpha

ProShares Ultra Health Care ETF (RXL)

  • Fri, Sep. 25, 3:07 PM
    | Fri, Sep. 25, 3:07 PM | 134 Comments
  • Apr. 4, 2014, 1:12 PM
    | Apr. 4, 2014, 1:12 PM | 6 Comments
  • May 6, 2013, 1:36 PM
    Merck (MRK -1.3%) gets no love today from the FDA's approval of Liptruxet late Friday, as the stock is likely dragged down with the rest of the big pharma names on the back of a CNBC report that criticizes their earnings so far. The article points to the fact that pharmaceutical companies have seen a 4.7% contraction in earnings, and a 3.2% drop in revenue this quarter. Why? Morningstar's Damien Cover says there are two primary reasons: FX impact, especially from the yen, and intensified generic competition from patent losses.
    | May 6, 2013, 1:36 PM | Comment!
  • Jun. 27, 2012, 3:05 PM
    Have a hankering to play the Obamacare ruling? It's risky, but if you must, here are a couple non-levered long-only ETF's ideas that traders are currently focused on: The Health Care Select Sector SPDR (XLV +1.1%) and the iShares Dow Jones U.S. Medical Devices Index Fund (IHI +1.6%). For the aggressive type, there are levered ETF's like: ProShares Ultra Health Care ETF (RXL +2.4%), or the Direxion Daily Healthcare Bull 3X Shares (CURE +4.5%). The tools are out there, how you use them is all up to you.
    | Jun. 27, 2012, 3:05 PM | Comment!
RXL vs. ETF Alternatives
RXL Description
ProShares Ultra Health Care seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Dow Jones U.S. Health Care IndexSM.
See more details on sponsor's website
Sector: Healthcare
Country: United States
Find the right ETFs for your portfolio: Visit Seeking Alpha's ETF Hub